Thyroid : official journal of the American Thyroid Association

publication venue for

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults. 2018
American Thyroid Association Scientific Statement on the Use of Potassium Iodide Ingestion in a Nuclear Emergency. 2017
American Thyroid Association Statement on Remote-Access Thyroid Surgery. 2016
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. 2016
Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. 2015
American Thyroid Association statement on optimal surgical management of goiter. 2014
American Thyroid Association statement on outpatient thyroidectomy. 2013
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. 2012
Hemorrhagic pseudoaneurysm in a patient receiving aflibercept for metastatic thyroid cancer. 2012
American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. 2012
Tract recurrence of a follicular thyroid neoplasm following transaxillary endoscopic thyroidectomy. 2012
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. 2011
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. 2009
Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma. 2007
Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma. 2007
Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma. 2007
Burkitt's lymphoma presenting as a rapidly growing thyroid mass. 2006
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. 2006
Ectopic intrathyroidal thymoma: a case report and review. 2003
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue. 2000
Regulation of Thyroid Hormone Levels by Hypothalamic Thyrotropin-Releasing Hormone Neurons. 2023
Prepubertal Children with Papillary Thyroid Carcinoma Present with More Invasive Disease Than Adolescents and Young Adults.. 33. 2022
Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.. 32. 2022
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.. 32. 2022
The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study.. 31. 2021
CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.. 31. 2021
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.. 31. 2020
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.. 30. 2020
Nondiagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants.. 30. 2020
Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma.. 30. 2020
Insurance Status Is Associated with Extent of Treatment for Patients with Papillary Thyroid Carcinoma.. 29. 2019
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.. 29. 2019
Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.. 29. 2019
Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.. 29. 2019
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.. 29. 2018
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.. 28. 2018
Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.. 28. 2018
Information for Clinicians: Approach to the Patient with Progressive Radioiodine-Refractory Thyroid Cancer-When to Use Systemic Therapy.. 27. 2017
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.. 27. 2017
Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.. 27. 2017
Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.. 27. 2017
Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.. 27. 2017
Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer.. 27. 2017
Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.. 26. 2016
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.. 26. 2016
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.. 26. 2016
Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.. 26. 2016
Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.. 26. 2016
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.. 26. 2015
Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?. 25. 2015
Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.. 25. 2015
Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.. 25. 2015
Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.. 25. 2015
Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer.. 25. 2015
Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.. 25. 2015
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.. 25. 2014
Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.. 24. 2014
Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.. 25. 2014
Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.. 24. 2014
Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.. 24. 2014
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).. 24. 2014
Prognostic implications of papillary thyroid carcinoma with tall-cell features.. 24. 2014
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.. 24. 2013
Ernest L. Mazzaferri, MD, MACP (1936-2013).. 23. 2013
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.. 23. 2013
Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.. 23. 2013
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.. 23. 2013
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.. 23. 2013
The increasing incidence of thyroid cancer: the influence of access to care.. 23. 2013
A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients.. 23. 2013
Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.. 22. 2012
Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.. 22. 2012
The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.. 22. 2012
Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer.. 22. 2012
Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.. 22. 2012
American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma.. 22. 2012
Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study.. 22. 2011
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response.. 21. 2011
Historical note: TSH suppression for thyroid cancer.. 21. 2011
Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression.. 21. 2011
Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.. 21. 2011
Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma.. 21. 2011
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.. 21. 2010
An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits.. 21. 2010
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.. 20. 2010
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension.. 20. 2010
Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.. 20. 2010
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.. 20. 2010
Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation.. 19. 2009
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?. 19. 2009
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).. 19. 2009
ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.. 18. 2008
Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.. 17. 2007
Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors.. 17. 2007
Outdated and incomplete: a review of thyroid cancer on the World Wide Web.. 17. 2007
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine.. 16. 2006
Recombinant human thyrotropin stimulates thyroid angiogenesis in vivo.. 16. 2006
Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors.. 16. 2006
Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling.. 15. 2005
BRAF mutations are uncommon in papillary thyroid cancer of young patients.. 15. 2005
Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.. 15. 2005
Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.. 15. 2005
Cytoplasmic localization of the paired box gene, Pax-8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence.. 14. 2004
Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer.. 13. 2003
Leucine at codon 428 in the ninth heptad of thyroid hormone receptor beta1 is necessary for interactions with the transcriptional cofactors and functions regardless of dimer formations.. 13. 2003
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.. 12. 2002
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.. 11. 2001
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.. 11. 2001
The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.. 10. 2000
Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.. 10. 2000
Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I.. 9. 1999
ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.. 8. 1998
Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.. 5. 1995
Reversal in Thyroid Cancer Incidence Trends in the United States, 2000-2017. 2020
Challenges of Active Surveillance Protocols for Low-Risk Papillary Thyroid Microcarcinoma in the United States. 2016
Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma". 2015
Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare. 2015
The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm. 2014
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. 2009
Thyroglobulin-positive, radioiodine-negative thyroid cancer. 2001
Summary of the Third World Congress on Thyroid Cancer.. 28. 2018
86th Annual Meeting of the American Thyroid Association.. 26. 2016
Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer-Primum Non Nocere and NIFTP.. 26. 2016
Welcome to the 84th annual meeting of the American Thyroid Association.. 24. 2014
Observing micopapillary thyroid cancers.. 24. 2014
Ultrasonographic characterization of cervical lymphadenopathy in chronic autoimmune thyroiditis.. 23. 2013
Thyroidectomy decreases snoring and sleep apnea: fact or fantasy?. 22. 2012
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer.. 21. 2011
Expanding indications for recombinant human TSH in thyroid cancer.. 18. 2008
Management of Invasive Differentiated Thyroid Cancer. 2016
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. 2015
Database and registry research in thyroid cancer: striving for a new and improved national thyroid cancer database. 2015
What is the gold standard for comprehensive interinstitutional communication of perioperative information for thyroid cancer patients? A comparison of existing electronic health records with the current American Thyroid Association recommendations. 2014
Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer. 2014
Improving the quality of thyroid cancer care: how does the Thyroid Cancer Care Collaborative cross the Institute of Medicine's Quality Chasm? 2014
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. 2012
American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. 2012
The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. 2008
Autoimmune thyroid disease associated with environmental thyroidal irradiation. 2003

VIVO Weill Cornell Medical College

Thyroid : official journal of the American Thyroid Association Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)